Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Completed 3Unknown 1Terminated 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Classical hematology 3Gastrointestinal 1Breast 1

Conditions

Breast Neoplasms 47Neutropenia 26Lymphoma 25Lymphoma, Non-Hodgkin 12Lymphoma, Large B-Cell, Diffuse 12Neoplasms 11Sarcoma 9Lymphoma, Follicular 9Ovarian Neoplasms 8Lymphoma, Mantle-Cell 8Leukemia 8Hodgkin Disease 8Carcinoma, Non-Small-Cell Lung 8Lung Neoplasms 7Leukemia, Lymphocytic, Chronic, B-Cell 7Triple Negative Breast Neoplasms 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Multiple Myeloma 5Lymphoma, B-Cell, Marginal Zone 5Chemotherapy-induced Neutropenia 5Rhabdomyosarcoma 4Neoplasm Metastasis 4Lymphoma, Large-Cell, Immunoblastic 4Burkitt Lymphoma 4Waldenstrom Macroglobulinemia 3Urinary Bladder Neoplasms 3Testicular Neoplasms 3Sarcoma, Synovial 3Prostatic Neoplasms 3Neurofibrosarcoma 3

Interventions

pegylated granulocyte colony-stimulating factor 3pegfilgrastim 3Vancomycin 3Interleukin 1 Receptor Antagonist Protein 2Filgrastim 2Ceftazidime 2Cefepime 2Amikacin 2Vaccination 1Teicoplanin 1Tazobactam 1Surveys and Questionnaires 1Sodium Chloride 1Positron Emission Tomography Computed Tomography 1Pneumococcal Vaccines 1Piperacillin 1N,N'-bis(pyridoxal-5-phosphate)ethylenediamine-N,N'-diacetic acid 1Meropenem 1Linezolid 1Itraconazole 1Injections 1Cloxacillin 1Ciprofloxacin 1Cilastatin, Imipenem Drug Combination 1Bevacizumab 1Anti-Bacterial Agents 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Febrile Neutropenia × pegfilgrastim × Clear all
NCT04460079 2020-07-07

Safety and Effectiveness Assessment of PeGagen® (Pegfilgrastim) in the Prevention of Chemotherapy-induced FN

Cinnagen

Completed
654 enrolled
Classical hematology

Febrile Neutropenia

NCT00536081 2019-11-06

Various G-CSF Regimens to Prevent Infection During Chemotherapy

Academisch Ziekenhuis Maastricht

Phase 3 Completed
172 enrolled
BreastClassical hematology

Breast Neoplasms, Febrile Neutropenia

NCT00911170 2017-12-29

PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation Study

Amgen

Phase 3 Completed
847 enrolled 21 charts
Classical hematologyGastrointestinal

Colonic Neoplasms, Fever, Neoplasms, Neutropenia, Rectal Neoplasms, Colorectal Neoplasms, Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡